Natural Products Expo East Preview: Aiding Gluten Digestion
Enzymedica is now introducing GlutenEase 2X.
As a follow-up to its original GlutenEase-a dietary supplement to help those who suffer from gluten intolerance digest and assimilate the offending proteins-Enzymedica is now introducing GlutenEase 2X. (Neither product is intended to be a treatment for those with celiac disease.)GlutenEase 2X contains a new Protease Thera-blend (G2) along with DPP-IV enzymes for providing double the digesting power of foods containing gluten and casein. The company says that the combination of Thera-blend (G2) and DPP-IV provides a minimum of two times the digestive support previously observed with its original Thera-blend in GlutenEase, breaking down at least twice as much gluten protein in less time. Additionally, the starch-digesting amylase enzymes in GlutenEase 2X assist in the digestion of the carbohydrate portion of grains, such as wheat, that contain gluten.
Enzymedica, Booth #5206
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
